HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Atypical toxoplasmic retinochoroiditis in patients with malignant hematological diseases.

Abstract
In immunocompromised patients, toxoplasmosis may have atypical presentation with bilateral, extensive or multifocal involvement. We report a case series of atypical toxoplasmic retinocoroiditis in patients with malignant hematological diseases who are usually immunosuppressed. Four patients were diagnosed of atypical toxoplasmic retinochoroiditis, all of them had immunosuppression (100%) and half of them (50%) had received a bone marrow transplant. The polymerase chain reaction for toxoplasma was positive in 75% of cases, and in one case (25%) the diagnosis was made with clinical and serological criteria. One patient presented ocular toxoplasmosis despite being on prophylactic treatment with atovaquone. Patients with atypical ocular toxoplasmosis and hematological diseases are generally immunocompromised, but they do not always have history of a bone marrow transplant. The presentation may be due to a primary infection or a reactivation of the disease. The aqueous humor and/or vitreous polymerase chain reaction allow confirming the diagnosis to perform a proper treatment.
AuthorsJ P Figueroa-Vercellino, L Miguel, A Moll-Udina, C Alba-Linero, V Llorenç, A Adán
JournalArchivos de la Sociedad Espanola de Oftalmologia (Arch Soc Esp Oftalmol (Engl Ed)) Vol. 96 Issue 3 Pg. 152-156 (Mar 2021) ISSN: 2173-5794 [Electronic] Spain
Vernacular TitleRetinocoroiditis toxoplásmica de presentación atípica en pacientes con enfermedades hematológicas malignas.
PMID32651033 (Publication Type: Case Reports)
CopyrightCopyright © 2020 Sociedad Española de Oftalmología. Publicado por Elsevier España, S.L.U. All rights reserved.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: